CA2481144A1 - Procedes et appareil destines a decontaminer des fluides - Google Patents
Procedes et appareil destines a decontaminer des fluides Download PDFInfo
- Publication number
- CA2481144A1 CA2481144A1 CA002481144A CA2481144A CA2481144A1 CA 2481144 A1 CA2481144 A1 CA 2481144A1 CA 002481144 A CA002481144 A CA 002481144A CA 2481144 A CA2481144 A CA 2481144A CA 2481144 A1 CA2481144 A1 CA 2481144A1
- Authority
- CA
- Canada
- Prior art keywords
- fluid
- ozone
- chamber
- ultrasonic energy
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000012530 fluid Substances 0.000 title claims abstract description 675
- 238000000034 method Methods 0.000 title claims abstract description 288
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 claims abstract description 469
- 238000011282 treatment Methods 0.000 claims abstract description 219
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 154
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 154
- 230000005855 radiation Effects 0.000 claims abstract description 62
- 239000013060 biological fluid Substances 0.000 claims abstract description 39
- 239000007788 liquid Substances 0.000 claims description 139
- 238000002156 mixing Methods 0.000 claims description 57
- 239000000758 substrate Substances 0.000 claims description 37
- 239000010409 thin film Substances 0.000 claims description 23
- 230000001678 irradiating effect Effects 0.000 claims description 16
- 238000005192 partition Methods 0.000 claims description 14
- 210000002381 plasma Anatomy 0.000 description 269
- 235000018102 proteins Nutrition 0.000 description 143
- 238000005202 decontamination Methods 0.000 description 126
- 230000003588 decontaminative effect Effects 0.000 description 112
- 238000002604 ultrasonography Methods 0.000 description 112
- 239000001301 oxygen Substances 0.000 description 101
- 229910052760 oxygen Inorganic materials 0.000 description 101
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 89
- 230000008569 process Effects 0.000 description 83
- 230000006378 damage Effects 0.000 description 82
- 238000007872 degassing Methods 0.000 description 79
- 239000007789 gas Substances 0.000 description 79
- 239000000463 material Substances 0.000 description 77
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 67
- 238000013459 approach Methods 0.000 description 60
- 241000700605 Viruses Species 0.000 description 55
- 210000004369 blood Anatomy 0.000 description 51
- 239000008280 blood Substances 0.000 description 51
- 238000012360 testing method Methods 0.000 description 49
- 244000052769 pathogen Species 0.000 description 42
- 238000012545 processing Methods 0.000 description 40
- 230000008901 benefit Effects 0.000 description 37
- 239000000306 component Substances 0.000 description 36
- 239000000047 product Substances 0.000 description 36
- 210000001772 blood platelet Anatomy 0.000 description 32
- 210000004027 cell Anatomy 0.000 description 32
- 238000005516 engineering process Methods 0.000 description 30
- 239000010836 blood and blood product Substances 0.000 description 29
- 230000000694 effects Effects 0.000 description 29
- 239000000356 contaminant Substances 0.000 description 28
- 210000003743 erythrocyte Anatomy 0.000 description 28
- 239000010410 layer Substances 0.000 description 28
- 241000282414 Homo sapiens Species 0.000 description 27
- 150000003254 radicals Chemical class 0.000 description 27
- 229940125691 blood product Drugs 0.000 description 26
- 238000010438 heat treatment Methods 0.000 description 25
- 239000012678 infectious agent Substances 0.000 description 24
- 239000007921 spray Substances 0.000 description 24
- 239000003795 chemical substances by application Substances 0.000 description 23
- 230000015572 biosynthetic process Effects 0.000 description 22
- 238000006243 chemical reaction Methods 0.000 description 20
- 230000002572 peristaltic effect Effects 0.000 description 19
- 230000002779 inactivation Effects 0.000 description 18
- 230000009467 reduction Effects 0.000 description 17
- 239000000243 solution Substances 0.000 description 17
- 102000004506 Blood Proteins Human genes 0.000 description 16
- 108010017384 Blood Proteins Proteins 0.000 description 16
- 241000125945 Protoparvovirus Species 0.000 description 15
- 239000004809 Teflon Substances 0.000 description 15
- 229920006362 Teflon® Polymers 0.000 description 15
- 238000001816 cooling Methods 0.000 description 15
- 239000004033 plastic Substances 0.000 description 15
- 229920003023 plastic Polymers 0.000 description 15
- 238000012546 transfer Methods 0.000 description 15
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 14
- 238000011109 contamination Methods 0.000 description 14
- 230000005684 electric field Effects 0.000 description 14
- 230000000670 limiting effect Effects 0.000 description 14
- 108020004414 DNA Proteins 0.000 description 13
- 238000009792 diffusion process Methods 0.000 description 13
- 230000005484 gravity Effects 0.000 description 13
- 230000001717 pathogenic effect Effects 0.000 description 13
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 12
- -1 oxygen radical Chemical class 0.000 description 12
- 238000005259 measurement Methods 0.000 description 11
- 241000283690 Bos taurus Species 0.000 description 10
- 102000008946 Fibrinogen Human genes 0.000 description 10
- 108010049003 Fibrinogen Proteins 0.000 description 10
- 241000725303 Human immunodeficiency virus Species 0.000 description 10
- 230000008878 coupling Effects 0.000 description 10
- 238000010168 coupling process Methods 0.000 description 10
- 238000005859 coupling reaction Methods 0.000 description 10
- 229940012952 fibrinogen Drugs 0.000 description 10
- 230000033001 locomotion Effects 0.000 description 10
- 229910052751 metal Inorganic materials 0.000 description 10
- 239000002184 metal Substances 0.000 description 10
- 230000036961 partial effect Effects 0.000 description 10
- 230000002829 reductive effect Effects 0.000 description 10
- 241000894007 species Species 0.000 description 10
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 9
- 238000010521 absorption reaction Methods 0.000 description 9
- 238000013461 design Methods 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- 241000894006 Bacteria Species 0.000 description 8
- 230000009471 action Effects 0.000 description 8
- 229960000074 biopharmaceutical Drugs 0.000 description 8
- 230000001413 cellular effect Effects 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 8
- 235000013305 food Nutrition 0.000 description 8
- 244000309711 non-enveloped viruses Species 0.000 description 8
- 230000003287 optical effect Effects 0.000 description 8
- 239000012460 protein solution Substances 0.000 description 8
- 238000010791 quenching Methods 0.000 description 8
- 238000003860 storage Methods 0.000 description 8
- 238000009210 therapy by ultrasound Methods 0.000 description 8
- 238000010792 warming Methods 0.000 description 8
- 239000012503 blood component Substances 0.000 description 7
- 230000015556 catabolic process Effects 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 210000000265 leukocyte Anatomy 0.000 description 7
- 238000012986 modification Methods 0.000 description 7
- 230000004048 modification Effects 0.000 description 7
- 229910052757 nitrogen Inorganic materials 0.000 description 7
- 244000045947 parasite Species 0.000 description 7
- 230000000171 quenching effect Effects 0.000 description 7
- 230000003612 virological effect Effects 0.000 description 7
- 102000001690 Factor VIII Human genes 0.000 description 6
- 108010054218 Factor VIII Proteins 0.000 description 6
- 241000233866 Fungi Species 0.000 description 6
- 238000002617 apheresis Methods 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 6
- 229910002092 carbon dioxide Inorganic materials 0.000 description 6
- 230000035602 clotting Effects 0.000 description 6
- 230000001276 controlling effect Effects 0.000 description 6
- 238000011161 development Methods 0.000 description 6
- 229960000301 factor viii Drugs 0.000 description 6
- 230000001976 improved effect Effects 0.000 description 6
- 208000015181 infectious disease Diseases 0.000 description 6
- 238000005457 optimization Methods 0.000 description 6
- 206010053567 Coagulopathies Diseases 0.000 description 5
- 241000702619 Porcine parvovirus Species 0.000 description 5
- 102000029797 Prion Human genes 0.000 description 5
- 108091000054 Prion Proteins 0.000 description 5
- 239000001569 carbon dioxide Substances 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 230000006835 compression Effects 0.000 description 5
- 238000007906 compression Methods 0.000 description 5
- 230000007423 decrease Effects 0.000 description 5
- 230000003247 decreasing effect Effects 0.000 description 5
- 238000006731 degradation reaction Methods 0.000 description 5
- 238000001514 detection method Methods 0.000 description 5
- 239000003599 detergent Substances 0.000 description 5
- 239000011521 glass Substances 0.000 description 5
- 230000012010 growth Effects 0.000 description 5
- 238000000338 in vitro Methods 0.000 description 5
- 230000001965 increasing effect Effects 0.000 description 5
- 238000011068 loading method Methods 0.000 description 5
- 238000012423 maintenance Methods 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 230000007246 mechanism Effects 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 238000012544 monitoring process Methods 0.000 description 5
- 238000011176 pooling Methods 0.000 description 5
- 239000010453 quartz Substances 0.000 description 5
- 238000005057 refrigeration Methods 0.000 description 5
- 230000001105 regulatory effect Effects 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 229910001220 stainless steel Inorganic materials 0.000 description 5
- 239000010935 stainless steel Substances 0.000 description 5
- 230000002195 synergetic effect Effects 0.000 description 5
- 239000012780 transparent material Substances 0.000 description 5
- 102000015081 Blood Coagulation Factors Human genes 0.000 description 4
- 108010039209 Blood Coagulation Factors Proteins 0.000 description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 4
- 238000013019 agitation Methods 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- 230000005540 biological transmission Effects 0.000 description 4
- 239000003114 blood coagulation factor Substances 0.000 description 4
- 239000012141 concentrate Substances 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 238000006073 displacement reaction Methods 0.000 description 4
- 238000007710 freezing Methods 0.000 description 4
- 230000008014 freezing Effects 0.000 description 4
- 239000005350 fused silica glass Substances 0.000 description 4
- 239000001257 hydrogen Substances 0.000 description 4
- 229910052739 hydrogen Inorganic materials 0.000 description 4
- 238000007654 immersion Methods 0.000 description 4
- 210000003041 ligament Anatomy 0.000 description 4
- 239000011159 matrix material Substances 0.000 description 4
- 230000010355 oscillation Effects 0.000 description 4
- 230000002035 prolonged effect Effects 0.000 description 4
- 238000005086 pumping Methods 0.000 description 4
- 230000009257 reactivity Effects 0.000 description 4
- 230000000630 rising effect Effects 0.000 description 4
- 238000005507 spraying Methods 0.000 description 4
- 231100000331 toxic Toxicity 0.000 description 4
- 230000002588 toxic effect Effects 0.000 description 4
- 230000032258 transport Effects 0.000 description 4
- 241000702617 Human parvovirus B19 Species 0.000 description 3
- 239000012298 atmosphere Substances 0.000 description 3
- 235000013405 beer Nutrition 0.000 description 3
- 230000004071 biological effect Effects 0.000 description 3
- 239000012620 biological material Substances 0.000 description 3
- 210000002421 cell wall Anatomy 0.000 description 3
- 238000004140 cleaning Methods 0.000 description 3
- 230000001351 cycling effect Effects 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000011049 filling Methods 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 238000005286 illumination Methods 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 238000005393 sonoluminescence Methods 0.000 description 3
- 238000009849 vacuum degassing Methods 0.000 description 3
- 208000030507 AIDS Diseases 0.000 description 2
- 241000710780 Bovine viral diarrhea virus 1 Species 0.000 description 2
- 241000222122 Candida albicans Species 0.000 description 2
- GUTLYIVDDKVIGB-OUBTZVSYSA-N Cobalt-60 Chemical compound [60Co] GUTLYIVDDKVIGB-OUBTZVSYSA-N 0.000 description 2
- 208000020406 Creutzfeldt Jacob disease Diseases 0.000 description 2
- 208000003407 Creutzfeldt-Jakob Syndrome Diseases 0.000 description 2
- 208000010859 Creutzfeldt-Jakob disease Diseases 0.000 description 2
- 241000701022 Cytomegalovirus Species 0.000 description 2
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 2
- 238000004435 EPR spectroscopy Methods 0.000 description 2
- 208000007985 Erythema Infectiosum Diseases 0.000 description 2
- 239000004606 Fillers/Extenders Substances 0.000 description 2
- 208000009329 Graft vs Host Disease Diseases 0.000 description 2
- 208000031220 Hemophilia Diseases 0.000 description 2
- 208000009292 Hemophilia A Diseases 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 241000598436 Human T-cell lymphotropic virus Species 0.000 description 2
- 241000701044 Human gammaherpesvirus 4 Species 0.000 description 2
- 241001529936 Murinae Species 0.000 description 2
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 230000003466 anti-cipated effect Effects 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 229940127219 anticoagulant drug Drugs 0.000 description 2
- 235000015197 apple juice Nutrition 0.000 description 2
- 230000002238 attenuated effect Effects 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 230000005779 cell damage Effects 0.000 description 2
- 208000037887 cell injury Diseases 0.000 description 2
- TVFDJXOCXUVLDH-RNFDNDRNSA-N cesium-137 Chemical compound [137Cs] TVFDJXOCXUVLDH-RNFDNDRNSA-N 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000004891 communication Methods 0.000 description 2
- 230000001010 compromised effect Effects 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 239000000498 cooling water Substances 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 230000001627 detrimental effect Effects 0.000 description 2
- 239000003651 drinking water Substances 0.000 description 2
- 235000013601 eggs Nutrition 0.000 description 2
- 229920001971 elastomer Polymers 0.000 description 2
- 238000007687 exposure technique Methods 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 230000004720 fertilization Effects 0.000 description 2
- 229920002313 fluoropolymer Polymers 0.000 description 2
- 239000004811 fluoropolymer Substances 0.000 description 2
- 238000005194 fractionation Methods 0.000 description 2
- 239000003292 glue Substances 0.000 description 2
- 208000024908 graft versus host disease Diseases 0.000 description 2
- 239000001307 helium Substances 0.000 description 2
- 229910052734 helium Inorganic materials 0.000 description 2
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 231100000283 hepatitis Toxicity 0.000 description 2
- 208000002672 hepatitis B Diseases 0.000 description 2
- 230000002706 hydrostatic effect Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000000415 inactivating effect Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 238000009434 installation Methods 0.000 description 2
- 229940008228 intravenous immunoglobulins Drugs 0.000 description 2
- 231100000518 lethal Toxicity 0.000 description 2
- 230000001665 lethal effect Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 238000000691 measurement method Methods 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 2
- 229910052753 mercury Inorganic materials 0.000 description 2
- 229910017604 nitric acid Inorganic materials 0.000 description 2
- 210000000287 oocyte Anatomy 0.000 description 2
- 238000006385 ozonation reaction Methods 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000000750 progressive effect Effects 0.000 description 2
- 239000003642 reactive oxygen metabolite Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 230000003068 static effect Effects 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 208000037918 transfusion-transmitted disease Diseases 0.000 description 2
- 230000001052 transient effect Effects 0.000 description 2
- 238000009827 uniform distribution Methods 0.000 description 2
- 238000009834 vaporization Methods 0.000 description 2
- 230000008016 vaporization Effects 0.000 description 2
- 230000035899 viability Effects 0.000 description 2
- 239000011800 void material Substances 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- 108010088751 Albumins Proteins 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 206010001935 American trypanosomiasis Diseases 0.000 description 1
- 241000272525 Anas platyrhynchos Species 0.000 description 1
- 206010003399 Arthropod bite Diseases 0.000 description 1
- 206010003504 Aspiration Diseases 0.000 description 1
- 241000606660 Bartonella Species 0.000 description 1
- 241000589562 Brucella Species 0.000 description 1
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 description 1
- 208000024699 Chagas disease Diseases 0.000 description 1
- 241000588919 Citrobacter freundii Species 0.000 description 1
- 201000007336 Cryptococcosis Diseases 0.000 description 1
- 241000221204 Cryptococcus neoformans Species 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241000283073 Equus caballus Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000481005 Escherichia coli O1 Species 0.000 description 1
- 241001646719 Escherichia coli O157:H7 Species 0.000 description 1
- 108010014172 Factor V Proteins 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010080379 Fibrin Tissue Adhesive Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 description 1
- 206010020843 Hyperthermia Diseases 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 241000222697 Leishmania infantum Species 0.000 description 1
- 241000186779 Listeria monocytogenes Species 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 108020005196 Mitochondrial DNA Proteins 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- 208000015914 Non-Hodgkin lymphomas Diseases 0.000 description 1
- 208000001388 Opportunistic Infections Diseases 0.000 description 1
- 241000282577 Pan troglodytes Species 0.000 description 1
- 208000008071 Parvoviridae Infections Diseases 0.000 description 1
- 206010057343 Parvovirus infection Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 230000005679 Peltier effect Effects 0.000 description 1
- 241000009328 Perro Species 0.000 description 1
- 241000224016 Plasmodium Species 0.000 description 1
- 241000223821 Plasmodium malariae Species 0.000 description 1
- 208000010378 Pulmonary Embolism Diseases 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000235344 Saccharomycetaceae Species 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 241000710960 Sindbis virus Species 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- 108090000190 Thrombin Proteins 0.000 description 1
- 208000004374 Tick Bites Diseases 0.000 description 1
- 208000003441 Transfusion reaction Diseases 0.000 description 1
- 241000223109 Trypanosoma cruzi Species 0.000 description 1
- 108020005202 Viral DNA Proteins 0.000 description 1
- 108010003533 Viral Envelope Proteins Proteins 0.000 description 1
- 108020000999 Viral RNA Proteins 0.000 description 1
- 208000027276 Von Willebrand disease Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 230000032912 absorption of UV light Effects 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000001147 anti-toxic effect Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 201000008680 babesiosis Diseases 0.000 description 1
- 235000015241 bacon Nutrition 0.000 description 1
- 238000010009 beating Methods 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 235000012206 bottled water Nutrition 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000005587 bubbling Effects 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 235000011089 carbon dioxide Nutrition 0.000 description 1
- 229910002091 carbon monoxide Inorganic materials 0.000 description 1
- 230000002612 cardiopulmonary effect Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 210000000080 chela (arthropods) Anatomy 0.000 description 1
- 230000002925 chemical effect Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 235000019987 cider Nutrition 0.000 description 1
- 150000001860 citric acid derivatives Chemical class 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 239000004035 construction material Substances 0.000 description 1
- 238000010924 continuous production Methods 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 229910001882 dioxygen Inorganic materials 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000011143 downstream manufacturing Methods 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000003670 easy-to-clean Effects 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 238000003487 electrochemical reaction Methods 0.000 description 1
- 238000005868 electrolysis reaction Methods 0.000 description 1
- 230000005672 electromagnetic field Effects 0.000 description 1
- 230000005670 electromagnetic radiation Effects 0.000 description 1
- 230000005686 electrostatic field Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 210000003013 erythroid precursor cell Anatomy 0.000 description 1
- BFMKFCLXZSUVPI-UHFFFAOYSA-N ethyl but-3-enoate Chemical compound CCOC(=O)CC=C BFMKFCLXZSUVPI-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000002360 explosive Substances 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 239000010408 film Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000002438 flame photometric detection Methods 0.000 description 1
- 229920002457 flexible plastic Polymers 0.000 description 1
- 230000009746 freeze damage Effects 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 230000005251 gamma ray Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 150000003278 haem Chemical group 0.000 description 1
- 238000005534 hematocrit Methods 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 229920001903 high density polyethylene Polymers 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 244000052637 human pathogen Species 0.000 description 1
- 210000004408 hybridoma Anatomy 0.000 description 1
- 230000036031 hyperthermia Effects 0.000 description 1
- 230000008105 immune reaction Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 229940072221 immunoglobulins Drugs 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 238000011005 laboratory method Methods 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 239000012263 liquid product Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 238000003754 machining Methods 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 230000007257 malfunction Effects 0.000 description 1
- 210000004779 membrane envelope Anatomy 0.000 description 1
- CXKWCBBOMKCUKX-UHFFFAOYSA-M methylene blue Chemical compound [Cl-].C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 CXKWCBBOMKCUKX-UHFFFAOYSA-M 0.000 description 1
- 229960000907 methylthioninium chloride Drugs 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229910017464 nitrogen compound Inorganic materials 0.000 description 1
- 150000002830 nitrogen compounds Chemical class 0.000 description 1
- 229910052756 noble gas Inorganic materials 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000006911 nucleation Effects 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 238000011275 oncology therapy Methods 0.000 description 1
- 235000015205 orange juice Nutrition 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 238000006213 oxygenation reaction Methods 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 238000009931 pascalization Methods 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 238000009832 plasma treatment Methods 0.000 description 1
- 229940118768 plasmodium malariae Drugs 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 238000007639 printing Methods 0.000 description 1
- 230000002250 progressing effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000011241 protective layer Substances 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000036632 reaction speed Effects 0.000 description 1
- 230000008263 repair mechanism Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 239000013557 residual solvent Substances 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 208000008864 scrapie Diseases 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 230000036561 sun exposure Effects 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 239000003894 surgical glue Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 201000010740 swine influenza Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 230000008646 thermal stress Effects 0.000 description 1
- 229960004072 thrombin Drugs 0.000 description 1
- 229940033618 tisseel Drugs 0.000 description 1
- 235000015193 tomato juice Nutrition 0.000 description 1
- 239000010891 toxic waste Substances 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 238000007514 turning Methods 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 238000004506 ultrasonic cleaning Methods 0.000 description 1
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
- 241001430294 unidentified retrovirus Species 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 238000013022 venting Methods 0.000 description 1
- 238000011179 visual inspection Methods 0.000 description 1
- 208000012137 von Willebrand disease (hereditary or acquired) Diseases 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
- A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
- A61L2/0094—Gaseous substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
- A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
- A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
- A61L2/0029—Radiation
- A61L2/0035—Gamma radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
- A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
- A61L2/0029—Radiation
- A61L2/0041—X-rays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
- A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
- A61L2/0029—Radiation
- A61L2/0058—Infrared radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
- A61L2/025—Ultrasonics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
- A61L2/20—Gaseous substances, e.g. vapours
- A61L2/202—Ozone
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Apparatus For Disinfection Or Sterilisation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Degasification And Air Bubble Elimination (AREA)
- Physical Or Chemical Processes And Apparatus (AREA)
- External Artificial Organs (AREA)
Abstract
Selon l'invention, des fluides, notamment des fluides biologiques contenant des protéines, en particulier du plasma, peuvent être décontaminés de manière efficace par traitement à l'énergie ultrasonore uniquement ou en conjugaison soit avec de l'ozone, soit avec un rayonnement UV. L'invention concerne également des appareils permettant de décontaminer des fluides biologiques contenant des protéines au moyen de ces procédés.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2002/008260 WO2003086479A1 (fr) | 2002-04-12 | 2002-04-12 | Procedes et appareil destines a decontaminer des fluides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2481144A1 true CA2481144A1 (fr) | 2003-10-23 |
Family
ID=29247951
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002481144A Abandoned CA2481144A1 (fr) | 2002-04-12 | 2002-04-12 | Procedes et appareil destines a decontaminer des fluides |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP1494723A4 (fr) |
| JP (1) | JP2005524683A (fr) |
| AU (1) | AU2002306757B2 (fr) |
| CA (1) | CA2481144A1 (fr) |
| MX (1) | MXPA04010027A (fr) |
| WO (1) | WO2003086479A1 (fr) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11426505B2 (en) | 2014-09-15 | 2022-08-30 | Sangair Ab | Apparatus and method for contacting blood with ozone |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7358505B2 (en) * | 1998-09-15 | 2008-04-15 | Baxter International Inc. | Apparatus for fabricating a reconstitution assembly |
| US20070102858A1 (en) * | 2005-11-07 | 2007-05-10 | Navigant Biotechnologies, Inc. | Clamps and methods for displacing fluid from portions of fluid containers |
| DE102005062410A1 (de) | 2005-12-23 | 2007-08-09 | Forschungsgemeinschaft Der Drk-Blutspendedienste E.V. | Verfahren zur Bestrahlung von Thrombozytenkonzentraten in flexiblen Behältnissen mit ultraviolettem Licht |
| DE102005062634A1 (de) | 2005-12-23 | 2007-06-28 | Blutspendedienst der Landesverbände des Deutschen Roten Kreuzes Niedersachsen, Sachsen-Anhalt, Thüringen, Oldenburg und Bremen gGmbH | Verfahren zur Inaktivierung von Pathogenen in Spenderblut, Blutplasma oder Erythrozytenkonzentraten in flexiblen Behältnissen unter Bewegung |
| DE102006027227A1 (de) | 2006-06-12 | 2008-01-03 | DRK - Blutspendedienst Baden-Württemberg-Hessen GmbH | Verfahren und Vorrichtung zum Inaktivieren von Viren und/oder Bakterien in flüssigen Medien, insbesondere in Blutplasmen und Serumkonserven |
| US7522702B2 (en) | 2006-08-29 | 2009-04-21 | Harris Corporation | Soft x-ray radiation for biological pathogen decontamination and medical sterilization applications |
| EP1902740A1 (fr) * | 2006-09-19 | 2008-03-26 | Maco Pharma S.A. | Système de poches de sang et méthode pour la neutralisation des pathogènes dans un concentré de plaquettes à l'aide de ce système de poches de sang |
| US7776260B2 (en) | 2006-12-11 | 2010-08-17 | Ethicon, Inc. | Apparatus and method for the irradiation of radiation sensitive materials |
| US8226894B2 (en) | 2006-12-20 | 2012-07-24 | Haru Miyake | Ultrasonic treatment apparatus |
| EP2008669A1 (fr) | 2007-06-22 | 2008-12-31 | Maco Pharma S.A. | Appareil d'irradiation pour rendre inactif les pathogènes et/ou leucocytes dans un liquide biologique et processus correspondant |
| ITMI20111439A1 (it) * | 2011-07-29 | 2013-01-30 | Paolo Benatti | Apparato per l'ozonizzazione di fluidi biologici, particolarmente per sangue. |
| WO2013106605A1 (fr) | 2012-01-11 | 2013-07-18 | Terumo Bct Biotechnologies, Llc | Clamp coulissant pour l'isolement d'orifice |
| CN114225067B (zh) * | 2021-12-22 | 2024-01-26 | 中国医学科学院输血研究所 | 一种血液病原体灭活方法 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4517159A (en) * | 1983-07-05 | 1985-05-14 | Karlson Eskil L | Sterilizer |
| US4632980A (en) * | 1985-04-03 | 1986-12-30 | Immunologics | Ozone decontamination of blood and blood products |
| FR2603805A1 (fr) * | 1986-09-16 | 1988-03-18 | Transfusion Sanguine Assoc Rgl | Procede d'inactivation par ozonolyse de micro-organismes contaminants presents dans des materiaux biologiques essentiellement proteiques, les produits obtenus et leurs applications biologiques et analytiques |
| JP3181071B2 (ja) * | 1991-06-28 | 2001-07-03 | 俊郎 立花 | 血液処理装置 |
| US5261874A (en) * | 1991-09-16 | 1993-11-16 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Extra-corporeal blood access, sensing, and radiation methods and apparatuses |
| JPH05104084A (ja) * | 1991-10-18 | 1993-04-27 | Nec Corp | 水中の有機塩素系溶剤成分を分解する方法およびその装置 |
| JP3429761B2 (ja) * | 1992-09-16 | 2003-07-22 | 株式会社 日立製作所 | 超音波照射装置及びそれによる処理装置 |
| US5370740A (en) * | 1993-10-01 | 1994-12-06 | Hughes Aircraft Company | Chemical decomposition by sonication in liquid carbon dioxide |
| US5466367A (en) * | 1994-04-06 | 1995-11-14 | Environmental Restoration Services, Inc. | Industrial waste water treatment |
| DK0840624T3 (da) * | 1995-07-14 | 2007-11-05 | Caf Dcf Cvba Scrl | Apparat til inaktivering af viruskontaminanter i blodprodukter |
| US5997812A (en) * | 1996-06-20 | 1999-12-07 | Coolant Treatment Systems, L.L.C. | Methods and apparatus for the application of combined fields to disinfect fluids |
| US6083387A (en) * | 1996-06-20 | 2000-07-04 | Burnham Technologies Ltd. | Apparatus for the disinfection of fluids |
| BE1010407A4 (fr) * | 1996-07-04 | 1998-07-07 | Undatim Ultrasonics | Procede et installation de traitement des eaux. |
| JP3464626B2 (ja) * | 1999-05-17 | 2003-11-10 | 秀幸 田淵 | 脱気殺菌装置 |
| US6802892B2 (en) * | 1999-09-16 | 2004-10-12 | Vasogen Ireland Limited | Apparatus and process for conditioning organic fluid |
| JP2001340452A (ja) * | 2000-05-31 | 2001-12-11 | Yoshiaki Nagaura | ウイルスを不活化する装置及び血液製剤の製造方法 |
| JP3479680B2 (ja) * | 2000-07-07 | 2003-12-15 | 独立行政法人産業技術総合研究所 | 超音波利用微小脱気装置 |
-
2002
- 2002-04-12 CA CA002481144A patent/CA2481144A1/fr not_active Abandoned
- 2002-04-12 AU AU2002306757A patent/AU2002306757B2/en not_active Expired - Fee Related
- 2002-04-12 JP JP2003583492A patent/JP2005524683A/ja active Pending
- 2002-04-12 EP EP02807229A patent/EP1494723A4/fr not_active Withdrawn
- 2002-04-12 MX MXPA04010027A patent/MXPA04010027A/es not_active Application Discontinuation
- 2002-04-12 WO PCT/US2002/008260 patent/WO2003086479A1/fr active Application Filing
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11426505B2 (en) | 2014-09-15 | 2022-08-30 | Sangair Ab | Apparatus and method for contacting blood with ozone |
Also Published As
| Publication number | Publication date |
|---|---|
| EP1494723A1 (fr) | 2005-01-12 |
| WO2003086479A1 (fr) | 2003-10-23 |
| AU2002306757B2 (en) | 2009-07-02 |
| MXPA04010027A (es) | 2005-07-01 |
| JP2005524683A (ja) | 2005-08-18 |
| AU2002306757A1 (en) | 2003-10-27 |
| EP1494723A4 (fr) | 2005-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7118852B2 (en) | Methods and apparatus for decontaminating fluids | |
| AU2002306757B2 (en) | Methods and apparatus for decontaminating fluids | |
| AU2010241297B2 (en) | Methods for uniformly treating biological samples with electromagnetic radiation | |
| US8525128B2 (en) | Method for the inactivation of pathogens in donor blood, blood plasma or erythrocyte concentrates in flexible containers under agitation | |
| US5030200A (en) | Method for eradicating infectious biological contaminants in body tissues | |
| US7011790B2 (en) | Non-thermal disinfection of biological fluids using non-thermal plasma | |
| JP2016027899A (ja) | 血液バッグシステム及び血液バッグシステムを用いた血小板濃縮物中の病原体を不活化する方法 | |
| US6346216B1 (en) | Method for sterilizing products | |
| US3837805A (en) | Apparatus for continuous sterilization at low temperature | |
| US3708263A (en) | Method for continuous sterilization at low temperature | |
| US9320995B2 (en) | Method and apparatus for processing sample material | |
| JP2009500123A (ja) | 生物学的サンプル中の病原体を減少させるための方法 | |
| US6696019B2 (en) | Rapid cryobaric sterilization and vaccine preparation | |
| MX2008008240A (es) | Procedimiento para irradiar concentrados de trombocitos en recipientes flexibles con luz ultravioleta. | |
| JPH0788182A (ja) | 体外循環血液治療装置 | |
| JPH05132424A (ja) | 赤血球を含む血液製剤の紫外線照射方法 | |
| TW200520799A (en) | Method for cleaning and sterilizing medical devices using dense phase fluid | |
| JPH11199490A (ja) | 活性酸素を用いた血液またはその成分の浄化方法 | |
| Purdum | Pathogen Inactivated Plasma Concentrated: Preparation and Uses |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| FZDE | Discontinued |